This program will target cardiovascular specialists, primary care physicians, and allied health professionals from across Canada.
View AgendaView Agenda
This program will cover the key clinical trial findings and their implications from AHA 2023. This program is intended for cardiovascular specialists and primary care physicians from across Canada.
This program was developed by CCRN and received an unrestricted educational grant from Novo Nordisk and Anthos Therapeutics.Back To Programs
BECOME A CCRN MEMBER
Being a part of CCRN has benefits